New intravenous treatments could help Louisiana TBI patients
Individuals who have had traumatic brain injuries may soon benefit from new intravenous treatments that are less invasive than traditional treatment options. TBIs range from mild concussions to violent injuries that result in long-term memory loss and other serious health issues. Approximately 2.5 million U.S. patients suffer from TBIs every year.
Inflammation and signaling difficulties are just two examples of the serious effects that can result from a traumatic brain injury. More than 100 compounds are used in preclinical tests to lessen brain damage, but it is not always easy to get them into the brain. There are no approved medications to stop the events leading up to secondary brain injury after a traumatic accident. Injecting drugs into the brain is an invasive procedure that often leads to other complications.
However, researchers have found a sequence of amino acids that recognizes injured tissues in the brain and could be used to deliver treatment. This treatment would potentially limit the damage that occurs after a traumatic brain injury with minimal invasiveness and could be administered through intravenous means. This innovative peptide tool could also be used to identify mild brain injuries in medical imaging devices. This would make diagnosis a more straightforward process.
Brain injuries can lead to serious, long-lasting medical issues and disability. Individuals who are unable to continue working after a traumatic head injury might be eligible to file for disability benefits. A lawyer may help individuals who were injured as a result of the negligence of another party receive compensation for treatment-related costs.
Tags: Brain Injuries